Kestra Medical Technologies, Ltd. (KMTS) Reports Q2 Loss of $2.21

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($2.21). Revenue for the quarter came in at $17.2 million.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• JPMorgan Reiterates Overweight Rating on Dixon Technologies India Ltd (DIXON:IN)
• Alphabet (GOOGL) Reiterated at Market Outperform by Citizens Amid Frontier Models Growth
• Morgan Stanley Starts Q32 Bio Inc. (QTTB) at Overweight